Search results

Glaukos backs FY24 revenue view $350M-$360M, consensus $352.71M » 07:06 GKOS Glaukos raises FY23 revenue view to $313M from $307M-$310M, consensus $309.02M » 07:05 GKOS Glaukos Corporation (GKOS)- Not quite a gummy but worth watching/// NYSE - NYSE Delayed Price. 82.00+2.89(+3.65%) At close...

Unfortunately I split my dating bets up. So hopefully Bumble will move here I actually own slightly more Bumble. :(

Good Morning. We have some movement on MTCH. I own this in one acct- We discussed the fact that swiping left & right will be on the increase in dating sites due to everyone losing weight./// Ozempic Effect))))))))))))))))))))))))))))))))))))) Match Group, Inc. (MTCH) NasdaqGS - NasdaqGS Real...

Tough to say how to handle this better. I don't like the running but it drew attention. I would first poke the eye out of one of the little dudes- hand strike. I keep my pinkie fingernails long for just this reason/ Then the one blind guy stumbling around is a message to the others. Then I run...

These AH quotes are usually not there the next day.... but Hell yea! Smartsheet Inc. (SMAR) NYSE - Nasdaq Real Time Price. 46.04+1.76(+3.97%) At close: 04:00PM EST 48.00+1.96(+4.26%)<---- please please please After hours:07:44PM EST

I am waiting for $6.05 the 1 month high to be taken out./- Still one of these small co's affected by high interest rates. Buy over $6.05 RKLB Rocket Lab USA, Inc. $5.550.15 (+2.78%)4:00 PM 01/08/24 NASDAQ | $USD | Post-Market: $5.67 +0.12 (+2.16%) 4:18 PM

B>R>E>A>K>I>N>G! United Airlines said to find loose bolts during 737 Max 9 inspections

One of our Sub sectors for Year24-- SPACe<---------- Rocket Lab selected by Space Development Agency for $515M contract » 16:06 RKLB

Confusing report lots of moving numbers))))))))) ACCD Beat their number. Accolade reports Q3 EPS (28c), consensus (44c) » 16:06 ACCD Reports Q3 revenue… :thumbsup: Accolade backs FY25 revenue view up 20%, consensus $493.01M :thumbsup:» 16:12 ACCD Backs FY25 adjusted… Accolade raises FY24...

Accolade, Inc. (ACCD) NasdaqGS - NasdaqGS Real Time Price. 11.62+0.48 (+4.31%) At close: 04:00PM EST 11.99 +0.37 (+3.18%)<---------- AH Special*****

Cramer he's not worth your time. I was going to go on about his latest failure when he bailed out of his tech. Such a dummy. It's not even worth going through his crap anymore whatever he says do the opposite and you'll be fine.

I made the appointment that took alot of guts. And bad feelings inside. Now I have to keep to it. I have a bad reputation of leaving my apartment for Dr's appointments and not showing up...

FormFactor, Inc. LIVERMORE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 26th Annual Needham Growth Conference on January 17, 2024. FormFactor is scheduled to present on Wednesday, January 17 at 9:30AM ET.

FORM I requested some research.. I'm ready for that research!-- Someone push me the info.

Is that $6.80 FNGR? Why Is Monday.com (MNDY) Stock Soaring Today. The Stock was named Stock Of The Week at gummybear advisors Mon, January 8, 2024, 2:03 PM EST In this article: MNDY +6.03% Why Is Monday.com (MNDY) Stock Soaring Today What Happened: Stonedinvestor upgraded the name & made it...

REVISITING A FORMER STOCK OF THE WEEK- SPHR SPHR up $7 since upgrade./ But up only $4 from the recovery print> We can certainly set some clear levels to buy this nae again. Guggenheim analyst Curry Baker lifted his rating on Sphere’s stock to Buy from Neutral after a recent selloff that saw...

BIRK $47 might run now that CROX has done it's thing. Boy did I nail this shoe thing or what!!! AI Ha! It's about experiences and in order to have experiences you must be wearing shoes. Call Of The New Year!!!! CROX Crocs, Inc. 104.09 +17.63 +20.40% DECK Deckers Outdoor Corporation 681.54...

Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout Deal Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout Deal Mon, January 8, 2024, 2:12 PM EST Symbol Last Price Change % Change CYTK Cytokinetics, Incorporated 104.51 +10.78 +11.50% Novartis is closing in on a...

I was nervous for you when you joked about the possibility the first time.